Unlocking the potential of
genomic medicine

2017 News Releases

Date Title
Toggle Summary11/08/2010
Misgav, Israel and London, UK -  8 November 2010 - Medgenics, Inc. (AIM: MEDG, MEDU), the company that has developed a novel technology for the manufacture and delivery of therapeutic proteins continuously in patients using their own tissue, is pleased to announce that has been awarded a cash
Toggle Summary10/27/2010
Toggle Summary10/19/2010
Toggle Summary09/23/2010
Toggle Summary09/02/2010
Toggle Summary09/01/2010
The Company has posted notice of its Annual Meeting of Stockholders (the "Notice") to be convened on September 13, 2010 in New York, New York, USA to its Stockholders of record as of August 20, 2010. The Notice is available on the Company's website at www.medgenics.com .
Toggle Summary08/24/2010
Misgav, Israel and London, UK - 24 August 2010 - Medgenics (AIM: MEDG and MEDU), the company that has developed a novel technology for the manufacture and delivery of therapeutic proteins continuously in patients using their own tissue, is seeking to raise additional funds to finance further
Toggle Summary08/23/2010
Toggle Summary07/19/2010
  Higher Dose EPO Biopumps Produce Dose-Dependent Increases in Haemoglobin      Misgav, Israel and London, UK -19 July 2010 - Medgenics, Inc. (AIM: MEDG, MEDU), the company that has developed a novel technology for the manufacture and delivery of therapeutic proteins
Toggle Summary06/22/2010
Misgav, Israel and London, UK -22 June 2010 - Medgenics, Inc. (AIM: MEDG, MEDU), the company that has developed a novel technology for the manufacture and delivery of therapeutic proteins continuously in patients using their own tissue, is pleased to announce that the first new patients have now